Talk:Dextrorphan: Difference between revisions
>Oskykins m Text replacement - " <ref>" to "<ref>" |
>ExistingEntity m Cleanup and addition of (stub) effects section |
||
Line 1: | Line 1: | ||
{{Stub}} | {{Stub}} | ||
Dextrorphan (DXO) is | '''Dextrorphan''' (also known as '''DXO''') is the main active metabolite of [[dextromethorphan]]. DXM is metabolized in the body by o-demethylation through the CYP2D6 enzyme to form DXO. Both are active chemicals and contribute to the [[DXM#Subjective effects|subjective effects]] experienced when active doses of DXM are consumed. | ||
==Pharmacology== | |||
The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an [[NMDA receptor antagonist]] as well as essentially inactive as a [[serotonin]] [[reuptake inhibitor]].<ref>Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study [http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=1998&issue=08000&article=00014&type=abstract]</ref> One Erowid user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | The pharmacology of dextrorphan is similar to that of dextromethorphan (DXM). However, dextrorphan is much more potent as an [[NMDA receptor antagonist]] as well as essentially inactive as a [[serotonin]] [[reuptake inhibitor]].<ref>Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism: A Pilot Study [http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=1998&issue=08000&article=00014&type=abstract]</ref> One Erowid user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | ||
"Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 [https://www.erowid.org/chemicals/dxm/dxm_info3.shtml]</ref> | "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 [https://www.erowid.org/chemicals/dxm/dxm_info3.shtml]</ref> | ||
==Subjective effects== | |||
{{Preamble/SubjectiveEffects}} | |||
===Physical effects=== | |||
*'''[[Effect::Appetite suppression]]''' | |||
*'''[[Effect::Changes in felt bodily form]]''' | |||
*'''[[Effect::Gustatory hallucinations]]''' | |||
*'''[[Effect::Itchiness]]''' - This effect has become subsequently known as "robo-itch" and though relatively common there are many users who never experience this particular effect while some individuals can experience it quite intensely. | |||
*'''[[Effect::Muscle spasms]]''' | |||
*'''[[Motor control loss|Motor control loss]]''' | |||
*'''[[Effect::Pain relief]]''' | |||
*'''[[Effect::Perception of decreased weight]]''' | |||
*'''[[Effect::Physical autonomy]]''' | |||
*'''[[Effect::Spatial disorientation]]''' | |||
*'''[[Effect::Tactile disconnection]]''' | |||
*'''[[Effect::Tactile suppression]]''' | |||
===Cognitive effects=== | |||
*'''[[Effect::Amnesia]]''' | |||
*'''[[Effect::Conceptual thinking]]''' | |||
*'''[[Effect::Consciousness disconnection]]''' | |||
*'''[[Effect::Creativity enhancement]]''' | |||
*'''[[Effect::Déjà vu]]''' | |||
*'''[[Effect::Depersonalization]]''' | |||
*'''[[Effect::Derealization]]''' | |||
*'''[[Effect::Disinhibition]]''' | |||
*'''[[Effect::Existential self-realization]]''' | |||
*'''[[Effect::Immersion enhancement]]''' | |||
*'''[[Effect::Increased music appreciation]]''' | |||
*'''[[Effect::Information processing suppression]]''' | |||
*'''[[Effect::Memory suppression]]''' | |||
*'''[[Effect::Novelty enhancement]]''' | |||
*'''[[Effect::Personal bias suppression]]''' | |||
*'''[[Effect::Thought deceleration]]''' | |||
*'''[[Effect::Time distortion]]''' | |||
*'''[[Effect::Unity and interconnectedness]]''' | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
Line 14: | Line 53: | ||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Psychoactive substance]] | |||
[[Category:Morphinan]] | [[Category:Morphinan]] | ||
[[Category:Dissociative]] | [[Category:Dissociative]] |